Paper Review Records
全部论文审稿周期
23 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
125
天
Exploration of Extravascular Tissue and Synovial Fluid Distribution of Extended Half-Life Factor IX Concentrates by Physiologically Based Pharmacokinetic Modelling
作者
Sjoerd F. Koopman; Erik Sjögren; Peter J. Lenting; Marjon H. Cnossen; Ron A. A. Mathôt展开收起
作者单位
1. Hospital Pharmacy-Clinical Pharmacology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands; 2. Department of Pharmaceutical Biosciences, Translational Drug Discovery and Development, Uppsala University, Uppsala, Sweden; 3. Pharmetheus, Uppsala, Sweden; 4. Université Paris-Saclay, Institut National de la Santé et de la Recherce Médicale (Inserm), Hémostase Inflammation Thrombose HITh U1176, Le Kremlin-Bicêtre, France; 5. Department of Pediatric Hematology and Oncology, Erasmus MC Sophia Children’s Hospital, University Medical Center Rotterdam, Rotterdam, The Netherlands展开收起
251
天
Once-Weekly Insulin Icodec: A Review of its Pharmacokinetic and Pharmacodynamic Properties
作者
T. Heise; M. P. Haridas; N. R. Kristensen; C. Mathieu; R. Ribel-Madsen; T. R. Pieber展开收起
作者单位
1. Profil, Neuss, Germany; 2. Novo Nordisk, Bangalore, India; 3. Novo Nordisk, Søborg, Denmark; 4. Clinical and Experimental Endocrinology, Katholieke Universiteit Leuven, Leuven, Belgium; 5. Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Graz, Austria展开收起
144
天
The Predictive Value of Gastrin for the Absorption of Erlotinib in Patients with Non-Small Cell Lung Cancer
作者
Niels Heersche; Daan A. C. Lanser; Sophie M. Ernst; Cornelis Kramers; Marthe S. Paats; Anne-Marie C. Dingemans; Ron H. N. van Schaik; Ron H. J. Mathijssen; G. D. Marijn Veerman展开收起
作者单位
1. Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands; 2. Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands; 3. Department of Pulmonology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands; 4. Department of Pharmacology-Toxicology and Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands展开收起
233
天
Population Pharmacokinetic/Pharmacodynamic Analysis of HHT120, a Novel Direct Thrombin Inhibitor, in Healthy Participants from a Phase I Clinical Trial
作者
Qingyu Yao; Xue Zhou; Yaou Liu; Jingyi Feng; Ran Xie; Runfeng Lin; Yongxing Wang; Qin Huang; Ying Zhou展开收起
作者单位
1. Clinical Trial Center, Beijing Key Laboratory of Clinical Pharmacology and Translation of Innovative Drugs, Peking University First Hospital, Beijing, China; 2. Livzon Pharmaceutical Group Co., Ltd., Zhuhai, China; 3. Department of Pharmacy, Peking University First Hospital, Beijing, China; 4. Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, China展开收起
244
天
The Variability in the Pharmacokinetics of Follitropin Alfa: A Systematic Review
作者
Ranita Kirubakaran; Toni J. F. Michael; Beverley J. Vollenhoven; Vinayak Smith; Sophie L. Stocker展开收起
作者单位
1. Department of Pharmacy, Seberang Jaya Hospital, Penang, Malaysia; 2. School of Clinical medicine, St. Vincent’s Healthcare Clinical Campus, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia; 3. School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; 4. Department of Obstetrics and Gynaecology, Monash University, Melbourne, Australia; 5. Monash IVF, Melbourne, Australia; 6. Women’s and Newborn Program, Monash Health, Melbourne, Australia; 7. Virtus Health Pty Ltd, Melbourne, Australia; 8. Department of Clinical Pharmacology and Toxicology, St. Vincent’s Hospital, Sydney, Australia展开收起
331
天
A Patient-Centered Approach for Drug–Drug Interaction (DDI) Assessment: Integrating Nested Clinical DDI Studies to Verify Translatability of Healthy Volunteer DDI Data, Minimize Stand-Alone Trials, and Enrich Drug Labeling
作者
Cheuk Fung Chan; Young Sun Scaringella; Fenglei Huang展开收起
作者单位
1. Clinical Pharmacology and Non-Clinical Safety Sciences, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, USA展开收起
FAQ
CLINICAL PHARMACOKINETICS审稿要多久?
截至2026-11-18,CrushSCI 收录了 CLINICAL PHARMACOKINETICS 的 23 篇完整审稿记录。最快一篇从收稿到录用用了 57 天(How Feasible is the Use of Saliva for Antiviral Therapeutic Drug Monitoring? A Systematic Review and Analysis,2026-04-21 收稿,2026-06-17 录用),最慢一篇用了 331 天;平均 151.8 天,中位数 130 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
